Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccine for COVID-19 Protection in Healthcare Workers
NCT04373291Phase 3Completed
- Sponsor
- Bandim Health Project
- Start
- May 2020
- Primary completion
- Jul 2021
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of bacillus calmette-guerin substrain danish 1331 live antigen in coronavirus disease 2019 (COVID-19), sponsored by Bandim Health Project. Started May 2020; status: completed.
02
Drugs
bacillus calmette-guerin substrain danish 1331 live antigen
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04373291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04373291.